vs

Side-by-side financial comparison of GRID DYNAMICS HOLDINGS, INC. (GDYN) and MEDIFAST INC (MED). Click either name above to swap in a different company.

GRID DYNAMICS HOLDINGS, INC. is the larger business by last-quarter revenue ($104.1M vs $75.1M, roughly 1.4× MEDIFAST INC). On growth, GRID DYNAMICS HOLDINGS, INC. posted the faster year-over-year revenue change (3.7% vs -36.9%). Over the past eight quarters, GRID DYNAMICS HOLDINGS, INC.'s revenue compounded faster (12.0% CAGR vs -34.4%).

Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

GDYN vs MED — Head-to-Head

Bigger by revenue
GDYN
GDYN
1.4× larger
GDYN
$104.1M
$75.1M
MED
Growing faster (revenue YoY)
GDYN
GDYN
+40.6% gap
GDYN
3.7%
-36.9%
MED
Faster 2-yr revenue CAGR
GDYN
GDYN
Annualised
GDYN
12.0%
-34.4%
MED

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
GDYN
GDYN
MED
MED
Revenue
$104.1M
$75.1M
Net Profit
$-1.5M
Gross Margin
34.8%
69.4%
Operating Margin
61.7%
-10.4%
Net Margin
-1.4%
Revenue YoY
3.7%
-36.9%
Net Profit YoY
-150.6%
EPS (diluted)
$-0.02
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GDYN
GDYN
MED
MED
Q1 26
$104.1M
Q4 25
$106.2M
$75.1M
Q3 25
$104.2M
$89.4M
Q2 25
$101.1M
$105.6M
Q1 25
$100.4M
$115.7M
Q4 24
$100.3M
$119.0M
Q3 24
$87.4M
$140.2M
Q2 24
$83.0M
$168.6M
Net Profit
GDYN
GDYN
MED
MED
Q1 26
$-1.5M
Q4 25
$306.0K
Q3 25
$1.2M
$-2.3M
Q2 25
$5.3M
$2.5M
Q1 25
$2.9M
$-772.0K
Q4 24
$4.5M
Q3 24
$4.3M
$1.1M
Q2 24
$-817.0K
$-8.2M
Gross Margin
GDYN
GDYN
MED
MED
Q1 26
34.8%
Q4 25
34.0%
69.4%
Q3 25
33.3%
69.5%
Q2 25
34.1%
72.6%
Q1 25
36.8%
72.8%
Q4 24
36.9%
74.1%
Q3 24
37.4%
75.4%
Q2 24
35.6%
73.2%
Operating Margin
GDYN
GDYN
MED
MED
Q1 26
61.7%
Q4 25
0.5%
-10.4%
Q3 25
-0.2%
-4.6%
Q2 25
-0.1%
-1.0%
Q1 25
-2.0%
-1.1%
Q4 24
1.3%
0.6%
Q3 24
2.4%
1.5%
Q2 24
0.0%
-4.7%
Net Margin
GDYN
GDYN
MED
MED
Q1 26
-1.4%
Q4 25
0.3%
Q3 25
1.1%
-2.5%
Q2 25
5.2%
2.3%
Q1 25
2.9%
-0.7%
Q4 24
4.5%
Q3 24
4.9%
0.8%
Q2 24
-1.0%
-4.8%
EPS (diluted)
GDYN
GDYN
MED
MED
Q1 26
$-0.02
Q4 25
$0.01
$-1.64
Q3 25
$0.01
$-0.21
Q2 25
$0.06
$0.22
Q1 25
$0.03
$-0.07
Q4 24
$0.06
$0.08
Q3 24
$0.05
$0.10
Q2 24
$-0.01
$-0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GDYN
GDYN
MED
MED
Cash + ST InvestmentsLiquidity on hand
$327.5M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$530.1M
$198.9M
Total Assets
$605.0M
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GDYN
GDYN
MED
MED
Q1 26
$327.5M
Q4 25
$342.1M
$167.3M
Q3 25
$338.6M
$173.5M
Q2 25
$336.8M
$162.7M
Q1 25
$325.5M
$164.6M
Q4 24
$334.7M
$162.3M
Q3 24
$231.3M
$170.0M
Q2 24
$256.0M
$163.5M
Stockholders' Equity
GDYN
GDYN
MED
MED
Q1 26
$530.1M
Q4 25
$542.1M
$198.9M
Q3 25
$537.7M
$214.7M
Q2 25
$532.2M
$216.0M
Q1 25
$517.4M
$211.0M
Q4 24
$517.8M
$210.1M
Q3 24
$400.2M
$207.3M
Q2 24
$388.4M
$205.3M
Total Assets
GDYN
GDYN
MED
MED
Q1 26
$605.0M
Q4 25
$612.9M
$248.0M
Q3 25
$613.2M
$268.2M
Q2 25
$608.9M
$269.3M
Q1 25
$590.9M
$280.0M
Q4 24
$592.2M
$284.2M
Q3 24
$477.3M
$291.2M
Q2 24
$443.6M
$293.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GDYN
GDYN
MED
MED
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GDYN
GDYN
MED
MED
Q1 26
Q4 25
$9.9M
$-5.3M
Q3 25
$7.0M
$12.1M
Q2 25
$14.4M
$-3.4M
Q1 25
$9.4M
$3.4M
Q4 24
$7.1M
$-4.9M
Q3 24
$9.2M
$9.1M
Q2 24
$10.7M
$13.1M
Free Cash Flow
GDYN
GDYN
MED
MED
Q1 26
Q4 25
$6.1M
$-6.6M
Q3 25
$2.9M
$10.8M
Q2 25
$10.2M
$-4.8M
Q1 25
$6.0M
$1.9M
Q4 24
$4.4M
$-7.2M
Q3 24
$5.9M
$7.7M
Q2 24
$8.0M
$11.1M
FCF Margin
GDYN
GDYN
MED
MED
Q1 26
Q4 25
5.7%
-8.8%
Q3 25
2.8%
12.0%
Q2 25
10.1%
-4.5%
Q1 25
6.0%
1.6%
Q4 24
4.4%
-6.1%
Q3 24
6.8%
5.5%
Q2 24
9.7%
6.6%
Capex Intensity
GDYN
GDYN
MED
MED
Q1 26
Q4 25
3.6%
1.8%
Q3 25
3.9%
1.5%
Q2 25
4.1%
1.3%
Q1 25
3.3%
1.3%
Q4 24
2.6%
1.9%
Q3 24
3.7%
1.0%
Q2 24
3.2%
1.1%
Cash Conversion
GDYN
GDYN
MED
MED
Q1 26
Q4 25
32.34×
Q3 25
5.92×
Q2 25
2.73×
-1.36×
Q1 25
3.21×
Q4 24
1.56×
Q3 24
2.15×
8.04×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons